Cost of cardiovascular diseases in the United Kingdom
Cost of cardiovascular diseases in the United Kingdom
复制标题
DOI：
10.1136/hrt.2005.072173
复制
发表时间：
2006-10-01
期刊：
影响因子：
5.7
通讯作者：
Rayner, M.
中科院分区：
文献类型：
--
作者：
Luengo-Fernandez, R.;Leal, J.;Rayner, M.
目的：估计英国心血管疾病（CVD）的经济负担，包括健康和非医疗保健费用，以及冠心病（CHD）和脑血管疾病在CVD总费用中所占的比例。设计和设置：从社会角度评估CVD相关费用的基于患病率的方法。患者：2004年所有英国居民CVD（国际疾病分类，第10次修订版（ICD-10）编码100-199）和CHD亚组（ICD-10代码120-125）或脑血管疾病（ICD-10编码160-169）.主要结果测量：医疗保健费用是根据社区卫生和社会服务、事故和紧急护理、医院护理、康复和药物的支出估计的。非医疗保健费用估计从非正式护理和生产力损失所产生的发病率和过早death.Results的数据：心血管疾病的成本英国经济29.1英镑十亿在2004年，冠心病和脑血管疾病占29%（8.5磅亿）和27%（8.0磅十亿）的总额，分别。心血管疾病的主要成本组成部分是医疗保健，占60%的成本，其次是生产力损失，由于死亡率和发病率，占23%，其余17%，由于非正式的护理相关costs.Conclusions：心血管疾病是一个领先的公共卫生问题，在英国衡量的疾病的经济负担。这项研究确定了这一负担的规模和主要组成部分，将有助于就研究优先事项作出知情决定，并监测政策举措的影响。
Objective: To estimate the economic burden of cardiovascular disease (CVD) in the United Kingdom, including health and non-healthcare costs, and the proportion of total CVD cost due to coronary heart disease (CHD) and cerebrovascular disease.Design and setting: Prevalence-based approach to assess CVD-related costs from a societal perspective.Patients: All UK residents in 2004 with CVD (International classification of diseases, 10th revision (ICD-10) codes 100-199) and subgroups with CHD (ICD-10 codes 120-125) or cerebrovascular disease (ICD-10 codes 160-169).Main outcome measures: Healthcare costs were estimated from expenditure on community health and social services, accident and emergency care, hospital care, rehabilitation and drugs. Non-healthcare costs were estimated from data on informal care and from productivity losses arising from morbidity and premature death.Results: CVD cost the UK economy 29.1 pound billion in 2004, with CHD and cerebrovascular disease accounting for 29% (8.5 pound billion) and 27% (8.0 pound billion) of the total, respectively. The major cost component of CVD was health care, which accounted for 60% of the cost, followed by productivity losses due to mortality and morbidity, accounting for 23%, with the remaining 17% due to informal care-related costs.Conclusions: CVD is a leading public health problem in the UK measured by the economic burden of disease. This study identified the size and main components of that burden, and will help to inform decisions about research priorities and to monitor the impact of policy initiatives.